Scientists are nervous about drug-resistant fungi : NPR

The Invisible Threat: The Rise of Drug-Resistant Fungi

While the world has focused heavily on antibiotic-resistant bacteria and antiviral challenges, a “silent surge” is happening under the radar: the rise of drug-resistant fungi.

Unlike bacteria, fungi present a unique biological challenge. For decades, this issue has remained largely overlooked, but experts now warn that the global impact is becoming impossible to ignore.

The danger ranges from irritating skin, hair, and nail infections to life-threatening bloodstream and lung infections, particularly in patients with compromised immunity.

From Farmland to Hospital: The Agricultural Link

One of the most surprising drivers of medical antifungal resistance isn’t found in the clinic, but in the field. Fungicides are used extensively to protect crops like wheat, maize, and watermelons to prevent yield losses of 30% to 40%.

The problem lies in the chemistry. Many agricultural fungicides are structurally similar to medical azoles—a primary class of antifungal drugs used in human medicine.

As fungi develop resistance to these agricultural chemicals, they simultaneously become resistant to the drugs doctors apply to treat patients. This cross-resistance travels through the air; mold spores can enter jet streams in the upper atmosphere and travel across continents before being inhaled by humans.

The Case of Candida auris: A Hospital Nightmare

Among the most concerning emerging threats is Candida auris, a type of yeast that has become a significant challenge in healthcare facilities.

In 2024, there were 6,304 reported clinical cases of C. Auris. This fungus is particularly dangerous because it is often multidrug-resistant and spreads easily among particularly sick patients.

What makes C. Auris a “nightmare” for infection control is its ability to colonize patients without causing symptoms. These colonized individuals can spread the yeast to surfaces and other patients without knowing they are carriers.

C. Auris can persist on surfaces for many months. It has been found on high-touch areas like bedrails and bedside tables, as well as distant surfaces like windowsills.

Why Fungi Are So Hard to Kill

Developing new antifungals is significantly harder than creating antibiotics. This is because fungal cells are structurally very similar to human cells.

Because of this similarity, it is difficult to find a drug that can kill the fungus without also harming the human host’s cells. This biological hurdle explains why only five classes of antifungals have been developed in the last 75 years.

When a fungus becomes resistant to the most important class—the azoles—doctors are often left with very few alternatives, especially for severe infections in the brain where few drugs can even penetrate.

Future Trends in Combatting the “Silent Surge”

The tide is beginning to turn as the global medical community recognizes that fungal resistance is a global, not local, problem. Several key trends are shaping the future of mycology:

• Global Surveillance: There is a growing push to establish laboratory networks and surveillance tools to track resistant strains in real-time, particularly in lower-middle-income countries where diagnostics are often unavailable.
• Fungicide Assessment: Experts are calling for new agricultural fungicides to undergo assessments to determine their impact on human fungal pathogens and the risk of cross-resistance.
• Institutional Prioritization: The World Health Organization (WHO) published its first-ever fungal pathogen list in 2022, signaling a major shift in how these threats are prioritized globally.

Frequently Asked Questions